Some 776,000 U.S. residents incur new genital herpes infections annually. There is no cure. Initial, positive results are reported for a therapeutic vaccine candidate for treating genital herpes.
Women seeking emergency contraception (EC) are at high risk of unintended pregnancy.
FHI 360 has launched its Contraceptive Technology Innovation Initiative to develop innovative, long-acting contraceptives.
As a healthcare provider, there are several things you can do to help women lower their risks for gynecologic cancer.
The Centers for Disease Control and Prevention (CDC) released its first U.S. Selected Practice Recommendations for Contraceptive Use (US SPR) in the June 21, 2013, Morbidity and Mortality Weekly Report. These practice recommendations address common, yet complex, issues surrounding initiating and using several contraceptive methods, and they serve as a resource for clinicians, including those who care for adolescents.